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Abstract
Nerve stimulation increases the concentration of ATP in the synaptic cleft, which can act as a neurotransmitter or as a presynaptic
neuromodulator. Using the luciferin-luciferase assay, we observed that the extracellular concentration of ATP increased by 11–26 nM over a
basal concentration of 6 nM, in a frequency dependent manner (1–5 Hz), in the adult rat phrenic nerve-hemidiaphragm preparation. This
ATP release depends on nerve activity since it was abolished by tetrodotoxin (1 mM) and is strictly dependent on the presence of extracellular
calcium. However, more than half of this nerve-evoked release of ATP is derived from activated muscle fibres since the selective post-
synaptic nicotinic receptor antagonist, a-bungarotoxin (1 mM), inhibited by over 60% the evoked release of ATP. The presently observed
post-synaptic release of ATP together with the previously reported lack of post-synaptic effects of ATP and to the ability of ATP to act as a
presynaptic modulator open the possibility that ATP may behave as a retrograde messenger at this neuromuscular junction.
q 2002 Elsevier Science Ireland Ltd. All rights reserved.
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In both peripheral and central synapses, it is now recognised
that the synaptic levels of ATP increase according to
neuronal activity and that this extracellular synaptic ATP
can act as a neurotransmitter or co-transmitter or as a
presynaptic neuromodulator (reviewed in ref. [4]). In central
nervous system (CNS) synapses like in the hippocampus,
ATP can act as a neurotransmitter [10,11] and the release of
ATP is enriched in presynaptic preparations (cf. [3,6]). In
contrast, at motor nerve endings, albeit the extracellular
levels of ATP are also increased on stimulation of nerve
afferents [16,17,19], there seems to be a considerably larger
contribution of post-synaptically released adenine nucleo-
tides [5,19]. And interestingly, at neuromuscular junctions,
ATP seems to be essentially devoid of direct post-synaptic
actions (reviewed in ref. [8]), acting mainly as a presynaptic
neuromodulator, either directly activating ATP (P2) recep-
tors [7,15] or acting via adenosine receptors upon its
extracellular catabolism into adenosine [2,14,16]. Also,
whereas the release of ATP from CNS preparations decays
during stimulation at lower frequencies [6], the release of
adenine nucleotides and of ATP seems to be sustained at
similar frequencies of stimulation at neuromuscular junc-
tions [5,19].
We now investigated the pattern of ATP release at the rat
innervated hemidiaphragm using different frequencies of
motor nerve stimulation to determine if ATP release
decreases on motor nerve stimulation and tested the effect
of D-tubocurarine and a-bungarotoxin, which block nerve-
evoked twitch contraction, to evaluate the respective
contribution of nerve and muscle fibres for ATP release.
The experimental protocol of ATP release from rat
innervated hemidiaphragm preparations (8 mm width)
evoked by phrenic nerve stimulation was as previously
described [15], with minor modifications. Preparations were
obtained from male Wistar rats 6 weeks old (about 130 g
weight), after anesthesia under halothane atmosphere. After
dissection, the preparations were mounted in 2 ml chambers,
with direct oxygenation (95% O2 and 5% CO2), kept at
378C, and superfused (3 ml/min) with Tyrode solution (also
continuously gassed) containing (mM): NaCl (137.0), KCl
(2.7), CaCl2 (1.8), MgCl2 (1.0), NaH2PO4 (0.4), NaHCO3
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(11.9), and glucose (11.2), pH 7.4. After a 30 min recovery
period, the superfusion was stopped. Bath samples (1.5 ml)
were collected every 3 min by completely emptying and
refilling the organ bath with the solution in use.
Two 3 min stimulation periods were applied (supramax-
imal square pulses with 15 V amplitude and 40 ms
duration), using different frequencies (1, 3 or 5 Hz), at 12
min (S1) and at 39 min (S2) after starting sample collection
(zero time). The evoked ATP release was calculated by
subtraction of the basal concentration from the total
concentration upon electrical stimulation. Test drugs (or
different superfusion media) were added 15 min before S2,
and were present up to the end of the experiments. The
change in the ratio between the evoked ATP released during
the two stimulation periods (S2/S1) relative to that observed
in control situations (in the absence of test drugs, i.e. with
control medium) was taken as a measure of the effect of the
tested drugs (tetrodotoxin, D-tubocurarine and a-bungar-
otoxin from Sigma).
ATP released from the preparations was assayed using
the luciferin–luciferase technique, as previously described
[6]. Briefly, 100 ml aliquots of the bath samples were added
to 100 ml of ATP assay mix (Sigma, containing firefly
luciferase 0.33 mg, luciferin 0.83 mg, MgSO4 6 mg, EDTA
2 mg, dithiothreitol 0.08 mg, bovine serum albumin 5 mg,
Tricine 45 mg, reconstituted in 5 ml of sterile water) and the
luminescence was measured in a BioOrbit 1250 lumin-
ometer for 15 s. Before the experiments a standard
calibration curve was prepared (ATP concentrations
between 1029 and 10212 M), and the levels of ATP in the
bath samples were calculated from a linear double log
fitting. The Tyrode solution without or with tested drugs was
assayed for background ATP content. The increase in the
bath concentration of ATP caused by electrical field
stimulation (evoked release) was calculated by subtracting
the basal concentration measured during the pre-stimulation
period from the concentration of ATP during the stimulation
period.
The results were evaluated by one-way analysis of
variance followed by Dunnett’s test (multiple comparisons),
or Student’s t-test (pairwise comparisons). P # 0:05 were
considered statistically significant. All data were expressed
as mean ^ SEM.
The basal concentration of extracellular ATP in rat
innervated hemidiaphragm preparations was 6.31 ^ 0.51
nM (n ¼ 21) and remained nearly constant during the time
of sample collection. As shown in Fig. 1A, electrical
stimulation of the phrenic nerve caused a marked increase in
the extracellular levels of ATP. When stimulated for 3 min
at 1 Hz, the evoked release of ATP was 11.2 ^ 0.7 nM
(n ¼ 6). A second identical stimulation period (S2)
delivered 24 min after the first stimulation period caused a
release of ATP similar (P . 0:05) to that released in the first
stimulation period, with an S2/S1 ratio of 1.02 ^ 0.12
(n ¼ 6). When we tested higher frequencies of nerve
stimulation, we found that ATP was released in a frequency
dependent manner (Fig. 1B). In fact, stimulation at 3 Hz for
3 min caused a release of ATP of 16.1 ^ 0.4 nM (n ¼ 6)
and stimulation at 5 Hz also for 3 min caused a release of
ATP of 23.6 ^ 0.7 nM (n ¼ 6). Again, when two periods of
stimulation were applied 24 min apart, the S2/S1 ratio was
near unit at both of these tested frequencies (1.04 ^ 0.06,
n ¼ 6, at 3 Hz and 1.10 ^ 0.13 at 5 Hz, n ¼ 6).
To further exclude the occurrence of a run-down of ATP
release during stimulation, as was observed to occur at 5 Hz
stimulation in rat hippocampal slices [6], we tested the
effect of increasing stimulation frequencies in the same
Fig. 1. Nerve stimulation triggers an evoked release of ATP that is
frequency-dependent. In A is shown a time course of ATP release,
quantified in the effluent with the luciferin-luciferase assay, upon
application of electrical stimulation through the phrenic nerve trunk (40
V, 40 ms, 1 Hz for 3 min) 12 min (S1) and 39 min (S2) after starting sample
collection, as indicated by the bars above the abscissa. The data are
mean ^ SEM of six experiments. Panel B presents the effect of increasing
frequencies of nerve stimulation on the evoked release of ATP, calculated
as the subtraction of the basal bath concentration from the total release of
ATP quantified on nerve stimulation. The results are mean ^ SEM of six
experiments at each frequency of stimulation. *P , 0:05.
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preparation. As illustrated in Table 1, there was an increased
release of ATP in S2, whenever the stimulation frequency
tested in S2 was greater than that used in S1, whereas the S2/
S1 ration was near unit when using any of the tested
stimulation frequencies (1, 3 or 5 Hz) both in S1 and in S2.
The nerve-evoked release of ATP was dependent on
neuronal activity since it was essentially abolished in the
presence of 1 mM tetrodotoxin (tested at 1 and 5 Hz, n ¼ 3
for each situation). As occurs for the vesicular release of
neurotransmitters, the nerve-evoked release of ATP was
also calcium-dependent since omission of calcium in the
superfusion solution during S2 essentially abolished the
evoked release of ATP (tested at 1 and 5 Hz n ¼ 3 for each
situation). To distinguish whether the release of ATP occurs
from the nerve terminals or from the activated muscle fibres,
we prevented nerve-evoked muscle fibre activation with D-
tubocurarine, which, at a concentration of 1 mM, blocks
nerve-evoked twitch contraction [12]. As documented in
Table 2, D-tubocurarine (1 mM) caused a decrease of over
50% in the nerve-evoked release of ATP, which was similar
(P . 0.05) with the different tested stimulation frequencies
(Table 2). However, since D-tubocurarine also affects the
nerve-evoked release of acetylcholine by interfering with
presynaptic facilitatory nicotinic acetylcholine receptors
[1], we tested the effect of another nicotinic receptor
antagonist, a-bungarotoxin, that selectively antagonises
post-synaptic nicotinic acetylcholine receptors in the rat
innervated hemidiaphragm (Correia-de-Sa´, personal com-
munication from submitted work). As documented in Table
3, a-bungarotoxin (1 mM) caused a decrease of over 60% in
the nerve-evoked release of ATP, which was similar
(P . 0:05) with the different tested stimulation frequencies
(Table 3).
Several works using different neuromuscular junctions
from different species and different stimulation patterns
have concluded that nerve stimulation triggers the release of
ATP [16,17,19]. There is some debate as to whether this
released ATP is originated from nerve terminals [16] or
from activated muscle fibres [19]. In the present work, we
have found that the release of ATP is frequency-dependent
and is partially reduced upon blockade of nicotinic
receptors. From our data, it appears that around 60% of
released ATP might be derived from the activated muscle
fibres, based on the inhibition caused by D-tubocurarine and
a-bungarotoxin. This is in good agreement with what was
found at the mouse hemidiaphragm [19].
Another conclusion from the present work is that the
release of ATP seems to be sustained during the stimulation
of the phrenic nerve at the tested frequencies, in contrast to
what is observed in hippocampal preparations [6] and to a
minor extend in innervated smooth muscle preparations
(e.g. ref. [18]). In fact, there is a clear frequency-dependent
increase in the nerve-evoked release of ATP and the
consecutive stimulation of the same preparations with
increasing frequencies of stimulation triggers the release
of increasing amounts of ATP. It is also interesting to note
that the absolute amounts of ATP detected in the bath of
stimulated hemidiaphragm preparations are larger than
these recorded in hippocampal or cortical preparations [6,
13]. This larger release of ATP at neuromuscular synapses
might be a consequence of the significant contribution of
activated muscle fibres for the nerve-evoked ATP release. In
fact, we now confirmed in the rat innervated hemidiaphragm
using different frequencies of nerve stimulation that more
than half of the released ATP might be derived from
activated muscle fibres, based on the ability of D-
tubocurarine and a-bungarotoxin to attenuated by over
50% the nerve-evoked ATP release. This scenario is
different from that found in CNS preparations, where
blockade of excitatory neurotransmission failed to signifi-
Table 1
Increasing frequencies of nerve stimulation cause an increase release of
ATPa
S1 (Hz) S2 (Hz) ATP (nM) S2/S1 n
S1 S2
1 3 11.2 ^ 0.7 15.9 ^ 0.7 1.41 ^ 0.10 6
1 5 12.4 ^ 0.6 26.3 ^ 1.1 2.12 ^ 0.13 6
3 5 16.1 ^ 0.4 21.4 ^ 2.4 1.33 ^ 0.15 6
a The same rat innervated hemidiaphragm preparation was stimulated
first at a lower frequency during 3 min (S1) and 24 min later at a higher
frequency also during 3 min (S2), which resulted in S2/S1 ratio always
greater (P , 0.05) than unit, whereas when the preparations were
stimulated at the same frequency during S1 and S2, the S2/S1 ration was
always near unit (n is the number of experiments).
Table 2
The nicotinic receptor antagonist, D-tubocurarine, in a concentration that
blocks nerve-evoked twitch contraction (1 mM), added 15 min before the
second stimulation period (S2), significantly attenuated (P , 0.05) the
nerve-evoked release of ATP (n is the number of experiments)
S1
(Hz)
S2
(Hz)
ATP (nM) S2/S1 % inhibition n
S1 S2
1 1 13.7 ^ 0.6 6.3 ^ 0.5 0.46 ^ 0.04 54 ^ 7 6
1 3 13.6 ^ 0.6 6.9 ^ 0.9 0.50 ^ 0.03 50 ^ 8 6
3 3 21.2 ^ 3.5 5.8 ^ 0.7 0.27 ^ 0.05 73 ^ 8 6
3 5 21.2 ^ 3.5 10.1 ^ 1.2 0.48 ^ 0.05 52 ^ 7 6
Table 3
The nicotinic receptor antagonist, a-bungarotoxin, in a concentration that
blocks nerve-evoked twitch contraction (1 mM), added 15 min before the
second stimulation period (S2), significantly attenuated (P , 0.05) the
nerve-evoked release of ATP (n is the number of experiments)
S1 (Hz) S2 (Hz) ATP (nM) S2/S1 % inhibition n
S1 S2
1 1 13.7 ^ 0.6 2.9 ^ 0.4 0.21 ^ 0.02 79 ^ 7 6
1 3 13.7 ^ 0.6 3.4 ^ 0.3 0.25 ^ 0.03 75 ^ 8 6
3 3 21.2 ^ 3.5 6.3 ^ 0.8 0.30 ^ 0.02 70 ^ 8 6
3 5 21.2 ^ 3.5 8.2 ^ 0.5 0.39 ^ 0.04 61 ^ 7 6
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cantly modify the evoked release of ATP [20] and where it
is observed that there is an enrichment of the specific
evoked ATP release when using purified nerve terminals (cf.
refs. [3,6]).
But the relevant question from the functional point of
view is what might be the role of extracellular ATP in the
control of neuromuscular transmission. Most reports have
concluded that exogenously added ATP, up to micromolar
concentrations, is devoid of effects on mature muscle fibres
(reviewed in ref. [8]). In fact, in mature neuromuscular
junctions, the only consensual role of extracellular ATP is to
presynaptically control the release of acetylcholine [2,7,
14–16]. However, whereas some reports concluded that
adenine nucleotides have to be extracellularly converted
into adenosine to modulate neurotransmitter release [2,14,
16], others have provided evidences that support a direct
presynaptic modulatory of ATP acting through P2 receptors
[7,15]. But, irrespective of whether extracellular ATP might
control the release of acetylcholine at the neuromuscular
junction via P1 or P2 receptors, the presently observed
significant contribution of the activated muscle fibres for the
accumulation of extracellular ATP opens the new possi-
bility that ATP may essentially fulfil a role of retrograde
messenger at these synapses, as previously proposed to
occur in the Torpedo electric organ [9].
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